These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Lung and Gut Microbiota Changes Associated with Bacci G; Rossi A; Armanini F; Cangioli L; De Fino I; Segata N; Mengoni A; Bragonzi A; Bevivino A Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830048 [TBL] [Abstract][Full Text] [Related]
34. Effects of Pseudomonas aeruginosa and Streptococcus mitis mixed infection on TLR4-mediated immune response in acute pneumonia mouse model. Song C; Li H; Zhang Y; Yu J BMC Microbiol; 2017 Apr; 17(1):82. PubMed ID: 28376744 [TBL] [Abstract][Full Text] [Related]
35. Gene Loss and Acquisition in Lineages of Pseudomonas aeruginosa Evolving in Cystic Fibrosis Patient Airways. Gabrielaite M; Johansen HK; Molin S; Nielsen FC; Marvig RL mBio; 2020 Oct; 11(5):. PubMed ID: 33109761 [TBL] [Abstract][Full Text] [Related]
36. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis. Pier GB; Grout M; Zaidi TS; Goldberg JB Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S175-82. PubMed ID: 8876538 [TBL] [Abstract][Full Text] [Related]
37. Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation. Yoo DG; Winn M; Pang L; Moskowitz SM; Malech HL; Leto TL; Rada B J Immunol; 2014 May; 192(10):4728-38. PubMed ID: 24740504 [TBL] [Abstract][Full Text] [Related]
38. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. Sagel SD; Gibson RL; Emerson J; McNamara S; Burns JL; Wagener JS; Ramsey BW; ; J Pediatr; 2009 Feb; 154(2):183-8. PubMed ID: 18822427 [TBL] [Abstract][Full Text] [Related]
39. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System. Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523 [TBL] [Abstract][Full Text] [Related]
40. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation. Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]